EchoSolv AS vs VX1+

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

EchoSolv AS

by Echo IQ

VX1+

by Volta Medical

AI Verdict

These tools are adjacent in the broader field of Cardiology AI but serve distinct clinical purposes. EchoSolv AS focuses on pre-procedural risk assessment for severe aortic stenosis using echocardiogram data, aiding in diagnosis and patient prioritization. In contrast, VX1+ provides real-time AI-driven insights to electrophysiologists during cardiac ablation procedures for atrial fibrillation and tachycardia, assisting with electrogram identification.

Choose EchoSolv AS if…

Choose EchoSolv AS if your cardiology department needs an efficient, AI-powered solution to accurately identify patients at high risk for severe aortic stenosis from existing echocardiogram measurements. This tool is ideal for streamlining diagnostic workflows, providing rapid risk detection, and prioritizing studies for closer review without requiring complex EMR integration.

View EchoSolv AS →

Choose VX1+ if…

Choose VX1+ if your electrophysiology lab requires real-time, AI-driven assistance during cardiac ablation procedures for atrial fibrillation or tachycardia. This software is best suited for electrophysiologists seeking to enhance the identification of abnormal electrograms and improve procedural outcomes by integrating AI insights directly into their existing EP recording and 3D mapping systems.

View VX1+ →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	EchoSolv AS	VX1+
Deployment	Cloud-based	Software, compatible with most multipolar catheters and mapping technologies used in operating rooms or electrophysiology labs.
BAA Available	Yes AI-estimated	Unknown
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Unknown

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	EchoSolv AS	VX1+
Primary Clinical Focus	Analyzes echocardiograms to identify patients at risk for severe aortic stenosis.	Assists electrophysiologists in real-time identification of abnormal electrograms during cardiac ablation procedures for atrial fibrillation and atrial tachycardia.
AI Mechanism/Input	Measurement-based AI (analyzes numerical measurements, not images); AI does not use LVOT measurements.	Identifies spatio-temporal dispersed electrograms (DEs); analyzes electrograms.
Real-time Capability	Ultra-fast risk detection (under 3 seconds)	Real-time identification of abnormal electrograms during cardiac ablation procedures
Integration	Designed to fit existing workflows (no EMR integration required, integrates with PACS)	Integrates with existing EP recording and 3D mapping systems (e.g., Boston Scientific LabSystem Pro, GE HealthCare MacLab CardioLab EP Recording System, Abbott EnSite X 3D mapping system)
Target User/Specialty	Cardiology, Cardiothoracic Surgery (specifically board-certified cardiologists)	Cardiology (specifically electrophysiologists)

Videos

Demos, reviews, and walkthroughs featuring EchoSolv AS and VX1+.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What is the primary clinical application of each tool?

EchoSolv AS is an AI-powered clinical decision support platform designed to analyze echocardiograms and identify patients at risk for severe aortic stenosis. VX1+ is AI-powered software that assists electrophysiologists in real-time identification of abnormal electrograms during cardiac ablation procedures for atrial fibrillation and atrial tachycardia.

Which medical specialties are these tools designed to support?

EchoSolv AS is primarily designed for Cardiology and Cardiothoracic Surgery, focusing on structural heart disease. VX1+ is specifically designed to assist electrophysiologists within Cardiology during cardiac ablation procedures.

What type of data does each AI tool analyze to provide insights?

EchoSolv AS analyzes numerical measurements from echocardiograms to assess severe aortic stenosis probability, rather than images. VX1+ analyzes multipolar intra-cardiac atrial electrograms and 3D anatomical and electrical maps of the human heart to identify spatio-temporal dispersed electrograms.

How do these tools integrate into existing clinical workflows?

EchoSolv AS is cloud-based and designed to fit existing workflows, integrating with PACS without requiring EMR integration. VX1+ is a software application that integrates with existing EP recording and 3D mapping systems, compatible with specific data acquisition systems like Boston Scientific LabSystem Pro or Abbott EnSite X 3D mapping system.

Do these tools provide real-time support or pre-procedural analysis?

EchoSolv AS provides pre-procedural clinical decision support for risk detection of severe aortic stenosis from existing echocardiogram data. VX1+ offers real-time AI-driven insights to assist electrophysiologists directly during cardiac ablation procedures.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform

AISAP Cardio vs Rapid Enterprise Platform

AngioWaveNet vs Rapid Enterprise Platform

CorVista System with PH Add-On vs Rapid Enterprise Platform